Bolar provisions in India's patent law


In May 2003, when India's Patent Act was amended, a new Section 107A was introduced. This provided for a research exemption as an exception to the general rules of patent infringement. Commonly known as a Bolar provision, this research exemption enables a manufacturer of generic drugs to use a patented invention to obtain marketing approval without the patent owner's permission before the patent expires. The generic drug maker...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Microsoft sues Samsung for breaking IP cross-licensing agreement http://t.co/POa9CvoLUk

Aug 1 2014 10:19 ·  reply ·  retweet ·  favourite
ManagingIP profile

Sounds messy RT @ReutersLegal: #Aereo, 'bleeding to death,' seeks emergency court help http://t.co/cm1xbWe0xA #IP

Aug 1 2014 03:29 ·  reply ·  retweet ·  favourite
ManagingIP profile

Could be some trademarks up for grabs ... RT @fastFT: P&G to shed up to 100 brands in streamlining http://t.co/FRPKgqRqkh

Aug 1 2014 01:14 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


July/August 2014

IP’s most influential people 2014

The 50 people in social media, advocacy and debate influencing IP policy



Most read articles

Supplements